BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35534674)

  • 1. Avoidance of cutaneous adverse drug reactions induced by antiepileptic drugs based on pharmacogenomics.
    Mushiroda T
    J Hum Genet; 2023 Mar; 68(3):227-230. PubMed ID: 35534674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
    Mortazavi H; Rostami A; Firooz A; Esmaili N; Ghiasi M; Lajevardi V; Amirzargar AA; Sheykhi I; Khamesipour A; Akhdar M
    Dermatol Ther; 2022 May; 35(5):e15393. PubMed ID: 35187767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population.
    Mushiroda T; Takahashi Y; Onuma T; Yamamoto Y; Kamei T; Hoshida T; Takeuchi K; Otsuka K; Okazaki M; Watanabe M; Kanemoto K; Oshima T; Watanabe A; Minami S; Saito K; Tanii H; Shimo Y; Hara M; Saitoh S; Kinoshita T; Kato M; Yamada N; Akamatsu N; Fukuchi T; Ishida S; Yasumoto S; Takahashi A; Ozeki T; Furuta T; Saito Y; Izumida N; Kano Y; Shiohara T; Kubo M;
    JAMA Neurol; 2018 Jul; 75(7):842-849. PubMed ID: 29610831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study.
    Shirzadi M; Thorstensen K; Helde G; Moen T; Brodtkorb E
    Epilepsy Res; 2015 Dec; 118():5-9. PubMed ID: 26555631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis.
    Sukasem C; Sririttha S; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Suvannang N; Rungrotmongkol T; Saokaew S; Aekplakorn W; Puangpetch A
    Pharmacogenomics J; 2021 Dec; 21(6):682-690. PubMed ID: 34175889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic literacy series: clinical application of pharmacogenetics for adverse reactions to antiepileptic drugs.
    Zhang Z; Wu Y; Tan NC; Jiang Y
    Epileptic Disord; 2019 Aug; 21(4):330-336. PubMed ID: 31403464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
    Ozeki T; Mushiroda T; Yowang A; Takahashi A; Kubo M; Shirakata Y; Ikezawa Z; Iijima M; Shiohara T; Hashimoto K; Kamatani N; Nakamura Y
    Hum Mol Genet; 2011 Mar; 20(5):1034-41. PubMed ID: 21149285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
    Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
    Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-associated antiepileptic drug-induced cutaneous adverse reactions.
    Mullan KA; Anderson A; Illing PT; Kwan P; Purcell AW; Mifsud NA
    HLA; 2019 Jun; 93(6):417-435. PubMed ID: 30895730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population.
    Ihtisham K; Ramanujam B; Srivastava S; Mehra NK; Kaur G; Khanna N; Jain S; Kumar S; Kaul B; Samudrala R; Tripathi M
    Seizure; 2019 Mar; 66():99-103. PubMed ID: 30826555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT
    Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.
    Greil W; Zhang X; Stassen H; Grohmann R; Bridler R; Hasler G; Toto S; Bleich S; Kasper S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between HLA-DRB1*0405, -DQB1*0401 and -DQA1*0303 alleles and lamotrigine-induced cutaneous adverse drug reactions. A pilot case-control study from Japan.
    Ito A; Shimada H; Ishikawa K; Takeo N; Hatano Y; Katagiri K; Kohno K; Araki Y; Terao T; Kojima H; Terao C; Eshima N; Fujiwara S
    J Affect Disord; 2015 Jul; 179():47-50. PubMed ID: 25845749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HLA Alleles with Antiepileptic Drug-Induced Mild Cutaneous Reactions: A Case-Control Study of a Northeast Han Chinese Population.
    Zhang W; Ye X; Meng H
    Neurol India; 2022; 70(5):2100-2105. PubMed ID: 36352615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous adverse drug reactions in children: an analysis of reports from the Canadian Pharmacogenomics Network for Drug Safety (CPNDS).
    Castro-Pastrana LI; Ghannadan R; Rieder MJ; Dahlke E; Hayden M; Carleton B
    J Popul Ther Clin Pharmacol; 2011; 18():e106-20. PubMed ID: 21467602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population.
    An DM; Wu XT; Hu FY; Yan B; Stefan H; Zhou D
    Epilepsy Res; 2010 Dec; 92(2-3):226-30. PubMed ID: 21071176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of
    Tiwattanon K; John S; Koomdee N; Jinda P; Rachanakul J; Jantararoungtong T; Nuntharadthanaphong N; Kloypan C; Biswas M; Boongird A; Sukasem C
    Front Pharmacol; 2022; 13():867490. PubMed ID: 35865943
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.
    He N; Min FL; Shi YW; Guo J; Liu XR; Li BM; Zhou JH; Ou YM; Liao JX; Liao WP
    Seizure; 2012 Oct; 21(8):614-8. PubMed ID: 22818943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
    Moon J; Kim TJ; Lim JA; Sunwoo JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Jeon D; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsia; 2016 Nov; 57(11):1879-1886. PubMed ID: 27666425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous Adverse Drug Reactions to Lamotrigine and Human Leukocyte Antigen Typing in North Indian Patients: A Case Series.
    Srivastava S; Ramanujam B; Ihtisham K; Tripathi M
    Ann Indian Acad Neurol; 2017; 20(4):408-410. PubMed ID: 29184346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.